Table of Content

1 Study Coverage
1.1 Antisense Oligonucleotides (ASO) Drug Product Introduction
1.2 Market by Type
1.2.1 Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fomivirsen
1.2.3 Spinraza
1.2.4 Tegsedi
1.2.5 Waylivra
1.2.6 Vyondys 53
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Single Gene Rare Disease
1.3.3 Protein Deposition Disease
1.3.4 Chronic Liver Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antisense Oligonucleotides (ASO) Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region
2.2.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2018-2024)
2.2.3 Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2024-2029)
2.2.4 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2018-2029)
2.3 Global Antisense Oligonucleotides (ASO) Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Antisense Oligonucleotides (ASO) Drug Sales by Region
2.4.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2018-2024)
2.4.3 Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2024-2029)
2.4.4 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Manufacturers
3.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antisense Oligonucleotides (ASO) Drug in 2022
3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Manufacturers
3.2.1 Global Antisense Oligonucleotides (ASO) Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antisense Oligonucleotides (ASO) Drug Revenue in 2022
3.3 Global Key Players of Antisense Oligonucleotides (ASO) Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antisense Oligonucleotides (ASO) Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Product Offered and Application
3.8 Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Type
4.1.1 Global Antisense Oligonucleotides (ASO) Drug Historical Sales by Type (2018-2024)
4.1.2 Global Antisense Oligonucleotides (ASO) Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
4.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Type
4.2.1 Global Antisense Oligonucleotides (ASO) Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Antisense Oligonucleotides (ASO) Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
4.3 Global Antisense Oligonucleotides (ASO) Drug Price by Type
4.3.1 Global Antisense Oligonucleotides (ASO) Drug Price by Type (2018-2024)
4.3.2 Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Application
5.1.1 Global Antisense Oligonucleotides (ASO) Drug Historical Sales by Application (2018-2024)
5.1.2 Global Antisense Oligonucleotides (ASO) Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
5.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Application
5.2.1 Global Antisense Oligonucleotides (ASO) Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Antisense Oligonucleotides (ASO) Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
5.3 Global Antisense Oligonucleotides (ASO) Drug Price by Application
5.3.1 Global Antisense Oligonucleotides (ASO) Drug Price by Application (2018-2024)
5.3.2 Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antisense Oligonucleotides (ASO) Drug Market Size by Type
6.1.1 US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2029)
6.1.2 US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2029)
6.2 US & Canada Antisense Oligonucleotides (ASO) Drug Market Size by Application
6.2.1 US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2029)
6.2.2 US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2029)
6.3 US & Canada Antisense Oligonucleotides (ASO) Drug Market Size by Country
6.3.1 US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2029)
6.3.3 US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antisense Oligonucleotides (ASO) Drug Market Size by Type
7.1.1 Europe Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2029)
7.1.2 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2029)
7.2 Europe Antisense Oligonucleotides (ASO) Drug Market Size by Application
7.2.1 Europe Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2029)
7.2.2 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2029)
7.3 Europe Antisense Oligonucleotides (ASO) Drug Market Size by Country
7.3.1 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2029)
7.3.3 Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antisense Oligonucleotides (ASO) Drug Market Size
8.1.1 China Antisense Oligonucleotides (ASO) Drug Sales (2018-2029)
8.1.2 China Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029)
8.2 China Antisense Oligonucleotides (ASO) Drug Market Size by Application
8.2.1 China Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2029)
8.2.2 China Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antisense Oligonucleotides (ASO) Drug Market Size by Type
9.1.1 Asia Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2029)
9.1.2 Asia Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2029)
9.2 Asia Antisense Oligonucleotides (ASO) Drug Market Size by Application
9.2.1 Asia Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2029)
9.2.2 Asia Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2029)
9.3 Asia Antisense Oligonucleotides (ASO) Drug Sales by Region
9.3.1 Asia Antisense Oligonucleotides (ASO) Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antisense Oligonucleotides (ASO) Drug Revenue by Region (2018-2029)
9.3.3 Asia Antisense Oligonucleotides (ASO) Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ionis
11.1.1 Ionis Company Information
11.1.2 Ionis Overview
11.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Ionis Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ionis Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Biogen
11.3.1 Biogen Company Information
11.3.2 Biogen Overview
11.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Biogen Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biogen Recent Developments
11.4 Akcea
11.4.1 Akcea Company Information
11.4.2 Akcea Overview
11.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Akcea Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Akcea Recent Developments
11.5 Therapeutics
11.5.1 Therapeutics Company Information
11.5.2 Therapeutics Overview
11.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Therapeutics Recent Developments
11.6 Sarepta Therapeutics
11.6.1 Sarepta Therapeutics Company Information
11.6.2 Sarepta Therapeutics Overview
11.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sarepta Therapeutics Recent Developments
11.7 WAVElife
11.7.1 WAVElife Company Information
11.7.2 WAVElife Overview
11.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 WAVElife Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 WAVElife Recent Developments
11.8 ProQR
11.8.1 ProQR Company Information
11.8.2 ProQR Overview
11.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 ProQR Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ProQR Recent Developments
11.9 Exicure
11.9.1 Exicure Company Information
11.9.2 Exicure Overview
11.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Exicure Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Exicure Recent Developments
11.10 Secarna
11.10.1 Secarna Company Information
11.10.2 Secarna Overview
11.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Secarna Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Secarna Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 The WhiteOak Group, Inc.
11.12.1 The WhiteOak Group, Inc. Company Information
11.12.2 The WhiteOak Group, Inc. Overview
11.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 The WhiteOak Group, Inc. Recent Developments
11.13 Dicerna
11.13.1 Dicerna Company Information
11.13.2 Dicerna Overview
11.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Dicerna Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dicerna Recent Developments
11.14 Silence
11.14.1 Silence Company Information
11.14.2 Silence Overview
11.14.3 Silence Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Silence Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Silence Recent Developments
11.15 Arrowhead
11.15.1 Arrowhead Company Information
11.15.2 Arrowhead Overview
11.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Arrowhead Recent Developments
11.16 Alnylam
11.16.1 Alnylam Company Information
11.16.2 Alnylam Overview
11.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Alnylam Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alnylam Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antisense Oligonucleotides (ASO) Drug Industry Chain Analysis
12.2 Antisense Oligonucleotides (ASO) Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antisense Oligonucleotides (ASO) Drug Production Mode & Process
12.4 Antisense Oligonucleotides (ASO) Drug Sales and Marketing
12.4.1 Antisense Oligonucleotides (ASO) Drug Sales Channels
12.4.2 Antisense Oligonucleotides (ASO) Drug Distributors
12.5 Antisense Oligonucleotides (ASO) Drug Customers
13 Market Dynamics
13.1 Antisense Oligonucleotides (ASO) Drug Industry Trends
13.2 Antisense Oligonucleotides (ASO) Drug Market Drivers
13.3 Antisense Oligonucleotides (ASO) Drug Market Challenges
13.4 Antisense Oligonucleotides (ASO) Drug Market Restraints
14 Key Findings in The Global Antisense Oligonucleotides (ASO) Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Fomivirsen
Table 3. Major Manufacturers of Spinraza
Table 4. Major Manufacturers of Tegsedi
Table 5. Major Manufacturers of Waylivra
Table 6. Major Manufacturers of Vyondys 53
Table 7. Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Antisense Oligonucleotides (ASO) Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Antisense Oligonucleotides (ASO) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2018-2024)
Table 12. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2024-2029)
Table 13. Global Antisense Oligonucleotides (ASO) Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2018-2024) & (K Units)
Table 15. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2024-2029) & (K Units)
Table 16. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2018-2024)
Table 17. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2024-2029)
Table 18. Global Antisense Oligonucleotides (ASO) Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Antisense Oligonucleotides (ASO) Drug Sales Share by Manufacturers (2018-2024)
Table 20. Global Antisense Oligonucleotides (ASO) Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Antisense Oligonucleotides (ASO) Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Antisense Oligonucleotides (ASO) Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Antisense Oligonucleotides (ASO) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Antisense Oligonucleotides (ASO) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides (ASO) Drug as of 2022)
Table 26. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Antisense Oligonucleotides (ASO) Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 31. Global Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 32. Global Antisense Oligonucleotides (ASO) Drug Sales Share by Type (2018-2024)
Table 33. Global Antisense Oligonucleotides (ASO) Drug Sales Share by Type (2024-2029)
Table 34. Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Type (2018-2024)
Table 37. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Type (2024-2029)
Table 38. Antisense Oligonucleotides (ASO) Drug Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 41. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 42. Global Antisense Oligonucleotides (ASO) Drug Sales Share by Application (2018-2024)
Table 43. Global Antisense Oligonucleotides (ASO) Drug Sales Share by Application (2024-2029)
Table 44. Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Application (2018-2024)
Table 47. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Application (2024-2029)
Table 48. Antisense Oligonucleotides (ASO) Drug Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Antisense Oligonucleotides (ASO) Drug Sales by Country (2024-2029) & (K Units)
Table 63. Europe Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 64. Europe Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 65. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 68. Europe Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 69. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Antisense Oligonucleotides (ASO) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Antisense Oligonucleotides (ASO) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2024) & (K Units)
Table 75. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2024-2029) & (K Units)
Table 76. China Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 77. China Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 78. China Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 81. China Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 82. China Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 85. Asia Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 86. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 89. Asia Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 90. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Antisense Oligonucleotides (ASO) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Antisense Oligonucleotides (ASO) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Antisense Oligonucleotides (ASO) Drug Sales by Region (2018-2024) & (K Units)
Table 96. Asia Antisense Oligonucleotides (ASO) Drug Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales by Country (2024-2029) & (K Units)
Table 110. Ionis Company Information
Table 111. Ionis Description and Major Businesses
Table 112. Ionis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Ionis Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Ionis Recent Developments
Table 115. Novartis Company Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Novartis Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Recent Developments
Table 120. Biogen Company Information
Table 121. Biogen Description and Major Businesses
Table 122. Biogen Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Biogen Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biogen Recent Developments
Table 125. Akcea Company Information
Table 126. Akcea Description and Major Businesses
Table 127. Akcea Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Akcea Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Akcea Recent Developments
Table 130. Therapeutics Company Information
Table 131. Therapeutics Description and Major Businesses
Table 132. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Therapeutics Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Therapeutics Recent Developments
Table 135. Sarepta Therapeutics Company Information
Table 136. Sarepta Therapeutics Description and Major Businesses
Table 137. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Sarepta Therapeutics Recent Developments
Table 140. WAVElife Company Information
Table 141. WAVElife Description and Major Businesses
Table 142. WAVElife Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. WAVElife Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. WAVElife Recent Developments
Table 145. ProQR Company Information
Table 146. ProQR Description and Major Businesses
Table 147. ProQR Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. ProQR Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. ProQR Recent Developments
Table 150. Exicure Company Information
Table 151. Exicure Description and Major Businesses
Table 152. Exicure Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Exicure Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Exicure Recent Developments
Table 155. Secarna Company Information
Table 156. Secarna Description and Major Businesses
Table 157. Secarna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Secarna Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Secarna Recent Developments
Table 160. AstraZeneca Company Information
Table 161. AstraZeneca Description and Major Businesses
Table 162. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. AstraZeneca Recent Developments
Table 165. The WhiteOak Group, Inc. Company Information
Table 166. The WhiteOak Group, Inc. Description and Major Businesses
Table 167. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. The WhiteOak Group, Inc. Recent Developments
Table 170. Dicerna Company Information
Table 171. Dicerna Description and Major Businesses
Table 172. Dicerna Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Dicerna Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Dicerna Recent Developments
Table 175. Silence Company Information
Table 176. Silence Description and Major Businesses
Table 177. Silence Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Silence Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Silence Recent Developments
Table 180. Arrowhead Company Information
Table 181. Arrowhead Description and Major Businesses
Table 182. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Arrowhead Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Arrowhead Recent Developments
Table 185. Alnylam Company Information
Table 186. Alnylam Description and Major Businesses
Table 187. Alnylam Antisense Oligonucleotides (ASO) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Alnylam Antisense Oligonucleotides (ASO) Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Alnylam Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Antisense Oligonucleotides (ASO) Drug Distributors List
Table 193. Antisense Oligonucleotides (ASO) Drug Customers List
Table 194. Antisense Oligonucleotides (ASO) Drug Market Trends
Table 195. Antisense Oligonucleotides (ASO) Drug Market Drivers
Table 196. Antisense Oligonucleotides (ASO) Drug Market Challenges
Table 197. Antisense Oligonucleotides (ASO) Drug Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Antisense Oligonucleotides (ASO) Drug Product Picture
Figure 2. Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antisense Oligonucleotides (ASO) Drug Market Share by Type in 2022 & 2029
Figure 4. Fomivirsen Product Picture
Figure 5. Spinraza Product Picture
Figure 6. Tegsedi Product Picture
Figure 7. Waylivra Product Picture
Figure 8. Vyondys 53 Product Picture
Figure 9. Global Antisense Oligonucleotides (ASO) Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application in 2022 & 2029
Figure 11. Single Gene Rare Disease
Figure 12. Protein Deposition Disease
Figure 13. Chronic Liver Disease
Figure 14. Others
Figure 15. Antisense Oligonucleotides (ASO) Drug Report Years Considered
Figure 16. Global Antisense Oligonucleotides (ASO) Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Antisense Oligonucleotides (ASO) Drug Revenue 2018-2029 (US$ Million)
Figure 18. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Region (2018-2029)
Figure 20. Global Antisense Oligonucleotides (ASO) Drug Sales 2018-2029 ((K Units)
Figure 21. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Antisense Oligonucleotides (ASO) Drug Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Antisense Oligonucleotides (ASO) Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Antisense Oligonucleotides (ASO) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Antisense Oligonucleotides (ASO) Drug Sales YoY (2018-2029) & (K Units)
Figure 27. China Antisense Oligonucleotides (ASO) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Antisense Oligonucleotides (ASO) Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Antisense Oligonucleotides (ASO) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Antisense Oligonucleotides (ASO) Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Antisense Oligonucleotides (ASO) Drug in the World: Market Share by Antisense Oligonucleotides (ASO) Drug Revenue in 2022
Figure 34. Global Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 36. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 37. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 38. Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Antisense Oligonucleotides (ASO) Drug Revenue Share by Country (2018-2029)
Figure 44. US & Canada Antisense Oligonucleotides (ASO) Drug Sales Share by Country (2018-2029)
Figure 45. U.S. Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 48. Europe Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 49. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 50. Europe Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 51. Europe Antisense Oligonucleotides (ASO) Drug Revenue Share by Country (2018-2029)
Figure 52. Europe Antisense Oligonucleotides (ASO) Drug Sales Share by Country (2018-2029)
Figure 53. Germany Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 54. France Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 58. China Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 59. China Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 60. China Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 61. China Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 63. Asia Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 64. Asia Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 65. Asia Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 66. Asia Antisense Oligonucleotides (ASO) Drug Revenue Share by Region (2018-2029)
Figure 67. Asia Antisense Oligonucleotides (ASO) Drug Sales Share by Region (2018-2029)
Figure 68. Japan Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 69. South Korea Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 70. China Taiwan Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Southeast Asia Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 72. India Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Revenue Share by Country (2018-2029)
Figure 78. Middle East, Africa and Latin America Antisense Oligonucleotides (ASO) Drug Sales Share by Country (2018-2029)
Figure 79. Brazil Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Mexico Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Turkey Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Israel Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 83. GCC Countries Antisense Oligonucleotides (ASO) Drug Revenue (2018-2029) & (US$ Million)
Figure 84. Antisense Oligonucleotides (ASO) Drug Value Chain
Figure 85. Antisense Oligonucleotides (ASO) Drug Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed